BioMed Research International / 2014 / Article / Tab 2 / Review Article
Diagnosis, Treatment, and Outcome in Patients with Bleeding Peptic Ulcers and Helicobacter pylori Infections Table 2 Incidence of rebleeding in
Hp -eradicated patients with no maintenance acid-suppressive therapy among different studies [
104 ].
Author Year and area Ulcer type Regimen ER number Mean F/U (M) Rebleeding number (%) Graham et al. [83 ] 1993, USA PU Triple 17 12 0 (0%) Labenz and Borsch [84 ] 1994, Germany PU 7 different protocols 42 17 0 (0%) Jaspersen et al. [86 ]
1995, Germany PU Dual 24 12 0 (0%) Jaspersen et al. [109 ] 1995, Germany DU Dual 29 12 1 (3.4%) Rokkas et al. [85 ] 1995, Greece DU Dual 13 12 0 (0%) Santander et al. [87 ] 1996, Spain PU Dual or triple 84 12 2 (2.3%) Riemann et al. [88 ] 1997, Germany PU Dual 42 19 2 (4.8%) Sung et al. [89 ] 1997, Hong Kong PU Triple 108 12 0 (0%) Macri et al. [110 ] 1998, Italy DU Quadruple 21 48 0 (0%) Amendola et al. [111 ] 1999, Argentina PU PPI 1-week regimen 42 24 0 (0%) Gisbert et al. [112 ] 1999, Spain DU Triple or dual 111 12 0 (0%) Lai et al. [113 ] 2000, Hong Kong DU Triple 41 53 2 (4.9%) Vergara et al. [95 ] 2000, Spain PU Triple or quadruple 93 27 0 (0%) Pellicano et al. [114 ] 2001, Italy DU Antibiotics 46 47 0 (0%) Capurso et al. [115 ] 2001, Italy DU Dual or triple 83 36 3 (3.3%) Arkkila et al. [96 ] 2003, Finland PU Quadruple or dual 176 12 2 (1.1%) Liu et al. [101 ] 2003, Taiwan PU Triple 26 56 0 (0%) Horvat et al. [116 ] 2005, Croatia GU Triple 43 12 1 (2.3%) Gisbert et al. [104 ] 2012, Spain PU Triple* 1000 39 5 (0.5%)
DU: duodenal ulcer; ER: eradication; F/U: followup; GU: gastric ulcer; PU: peptic ulcer (gastric or duodenal ulcer).
*Triple therapy first followed by 2nd-, 3rd-, or 4th-line treatment.